Tag: NASDAQ:TLGT

October 2, 2018

Teligent Announces FDA Approval of Fluocinonide Ointment USP, 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...
June 13, 2018

Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...